373 related articles for article (PubMed ID: 32983101)
1. Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium.
Creyns B; Jacobs I; Verstockt B; Cremer J; Ballet V; Vandecasteele R; Vanuytsel T; Ferrante M; Vermeire S; Van Assche G; Ceuppens JL; Breynaert C
Front Immunol; 2020; 11():1847. PubMed ID: 32983101
[TBL] [Abstract][Full Text] [Related]
2. Distinct Alterations in the Composition of Mucosal Innate Lymphoid Cells in Newly Diagnosed and Established Crohn's Disease and Ulcerative Colitis.
Forkel M; van Tol S; Höög C; Michaëlsson J; Almer S; Mjösberg J
J Crohns Colitis; 2019 Jan; 13(1):67-78. PubMed ID: 30496425
[TBL] [Abstract][Full Text] [Related]
3. ILC3 function as a double-edged sword in inflammatory bowel diseases.
Zeng B; Shi S; Ashworth G; Dong C; Liu J; Xing F
Cell Death Dis; 2019 Apr; 10(4):315. PubMed ID: 30962426
[TBL] [Abstract][Full Text] [Related]
4. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
[TBL] [Abstract][Full Text] [Related]
5. Crohn's Disease Is Associated With Activation of Circulating Innate Lymphoid Cells.
Mazzurana L; Bonfiglio F; Forkel M; D'Amato M; Halfvarson J; Mjösberg J
Inflamm Bowel Dis; 2021 Jun; 27(7):1128-1138. PubMed ID: 33295628
[TBL] [Abstract][Full Text] [Related]
6. Innate lymphoid cells in homeostasis, infection, chronic inflammation and tumors of the gastrointestinal tract.
Fuchs A; Colonna M
Curr Opin Gastroenterol; 2013 Nov; 29(6):581-7. PubMed ID: 24100718
[TBL] [Abstract][Full Text] [Related]
7.
Tang Y; Tan SA; Iqbal A; Li J; Glover SC
J Immunol Res; 2019; 2019():9406146. PubMed ID: 31321245
[TBL] [Abstract][Full Text] [Related]
8. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis.
Villanova F; Flutter B; Tosi I; Grys K; Sreeneebus H; Perera GK; Chapman A; Smith CH; Di Meglio P; Nestle FO
J Invest Dermatol; 2014 Apr; 134(4):984-991. PubMed ID: 24352038
[TBL] [Abstract][Full Text] [Related]
9. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis.
Ciccia F; Guggino G; Rizzo A; Saieva L; Peralta S; Giardina A; Cannizzaro A; Sireci G; De Leo G; Alessandro R; Triolo G
Ann Rheum Dis; 2015 Sep; 74(9):1739-47. PubMed ID: 25902790
[TBL] [Abstract][Full Text] [Related]
10. The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis.
Overstreet AM; LaTorre DL; Abernathy-Close L; Murphy SF; Rhee L; Boger AM; Adlaka KR; Iverson AM; Bakke DS; Weber CR; Boone DL
Mucosal Immunol; 2018 Sep; 11(5):1454-1465. PubMed ID: 29988117
[TBL] [Abstract][Full Text] [Related]
11. Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents.
Iborra M; Beltrán B; Maroto N; Navarro-Cortés P; Boscá-Watts M; Ferrer-Bradley I; García-Morales N; Sáez-González E; Hinojosa J; Mínguez M; Nos P
Gastroenterol Hepatol; 2018 Nov; 41(9):535-543. PubMed ID: 30031573
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation.
Powell N; Lo JW; Biancheri P; Vossenkämper A; Pantazi E; Walker AW; Stolarczyk E; Ammoscato F; Goldberg R; Scott P; Canavan JB; Perucha E; Garrido-Mesa N; Irving PM; Sanderson JD; Hayee B; Howard JK; Parkhill J; MacDonald TT; Lord GM
Gastroenterology; 2015 Aug; 149(2):456-67.e15. PubMed ID: 25917784
[TBL] [Abstract][Full Text] [Related]
13. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
14. Reduced CD27
Pararasa C; Zhang N; Tull TJ; Chong MHA; Siu JHY; Guesdon W; Chavele KM; Sanderson JD; Langmead L; Kok K; Spencer J; Vossenkamper A
Front Immunol; 2019; 10():361. PubMed ID: 30891036
[TBL] [Abstract][Full Text] [Related]
15. Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease.
Zeissig S; Rosati E; Dowds CM; Aden K; Bethge J; Schulte B; Pan WH; Mishra N; Zuhayra M; Marx M; Paulsen M; Strigli A; Conrad C; Schuldt D; Sinha A; Ebsen H; Kornell SC; Nikolaus S; Arlt A; Kabelitz D; Ellrichmann M; Lützen U; Rosenstiel PC; Franke A; Schreiber S
Gut; 2019 Jan; 68(1):25-39. PubMed ID: 29730603
[TBL] [Abstract][Full Text] [Related]
16. Wogonin improves colitis by activating the AhR pathway to regulate the plasticity of ILC3/ILC1.
Ye Q; Huang S; Wang Y; Chen S; Yang H; Tan W; Wu Z; Wang A; Chen Y
Phytomedicine; 2024 Jun; 128():155425. PubMed ID: 38518634
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of Group 3 Innate Lymphoid Cells in the Pathogenesis of Inflammatory Bowel Disease.
Forkel M; Mjösberg J
Curr Allergy Asthma Rep; 2016 Oct; 16(10):73. PubMed ID: 27645534
[TBL] [Abstract][Full Text] [Related]
18. Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells.
Eken A; Yetkin MF; Vural A; Okus FZ; Erdem S; Azizoglu ZB; Haliloglu Y; Cakir M; Turkoglu EM; Kilic O; Kara I; Dönmez Altuntaş H; Oukka M; Kutuk MS; Mirza M; Canatan H
Front Immunol; 2019; 10():217. PubMed ID: 30828332
[TBL] [Abstract][Full Text] [Related]
19. Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease.
Barré A; Colombel JF; Ungaro R
Aliment Pharmacol Ther; 2018 Apr; 47(7):896-905. PubMed ID: 29430672
[TBL] [Abstract][Full Text] [Related]
20. Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis.
Ribaldone DG; Pellicano R; Vernero M; Caviglia GP; Saracco GM; Morino M; Astegiano M
Scand J Gastroenterol; 2019 Apr; 54(4):407-413. PubMed ID: 30945576
[No Abstract] [Full Text] [Related]
[Next] [New Search]
